XML 18 R7.htm IDEA: XBRL DOCUMENT v3.20.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Class A and B Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2018   141,927,205      
Beginning balance at Dec. 31, 2018 $ 194,671 $ 14 $ 609,697 $ 0 $ (415,040)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Vesting of restricted stock units (in shares)   3,004,471      
Exercise of stock options, net (in shares)   1,234,290      
Issuance of common stock upon exercise of stock options 1,924 $ 1 1,923    
Stock-based compensation 11,953   11,953    
Comprehensive income (loss) (28,249)     7 (28,256)
Ending balance (in shares) at Sep. 30, 2019   146,165,966      
Ending balance at Sep. 30, 2019 180,299 $ 15 623,573 7 (443,296)
Beginning balance (in shares) at Jun. 30, 2019   145,198,887      
Beginning balance at Jun. 30, 2019 186,510 $ 14 620,449 7 (433,960)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Vesting of restricted stock units (in shares)   913,573      
Exercise of stock options, net (in shares)   53,506      
Issuance of common stock upon exercise of stock options 79 $ 1 78    
Stock-based compensation 3,046   3,046    
Comprehensive income (loss) (9,336)       (9,336)
Ending balance (in shares) at Sep. 30, 2019   146,165,966      
Ending balance at Sep. 30, 2019 180,299 $ 15 623,573 7 (443,296)
Beginning balance (in shares) at Dec. 31, 2019   148,209,215      
Beginning balance at Dec. 31, 2019 $ 172,874 $ 15 627,899 2 (455,042)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Vesting of restricted stock units (in shares)   4,925,493      
Exercise of stock options, net (in shares) 172,729 172,729      
Issuance of common stock upon exercise of stock options $ 178   178    
Issuance of common stock under the ESPP (in shares)   467,522      
Issuance of common stock under the ESPP 371   371    
Stock-based compensation 9,623   9,623    
Comprehensive income (loss) (60,988)     (2) (60,986)
Ending balance (in shares) at Sep. 30, 2020   153,774,959      
Ending balance at Sep. 30, 2020 122,058 $ 15 638,071 0 (516,028)
Beginning balance (in shares) at Jun. 30, 2020   150,626,427      
Beginning balance at Jun. 30, 2020 119,164 $ 15 634,730 0 (515,581)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Vesting of restricted stock units (in shares)   2,893,017      
Exercise of stock options, net (in shares)   30,000      
Issuance of common stock upon exercise of stock options 23   23    
Issuance of common stock under the ESPP (in shares)   225,515      
Issuance of common stock under the ESPP 185   185    
Stock-based compensation 3,133   3,133    
Comprehensive income (loss) (447)       (447)
Ending balance (in shares) at Sep. 30, 2020   153,774,959      
Ending balance at Sep. 30, 2020 $ 122,058 $ 15 $ 638,071 $ 0 $ (516,028)